Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Align Technology (ALGN)

Align Technology (ALGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Bear of the Day: Align Technology (ALGN)

Align Technology (ALGN) is a Zacks Rank #5 (Strong Sell) that is a global leader in digital orthodontics and the creator of the Invisalign clear aligner system.Align recently reported earnings, with an...

BDX : 235.24 (+0.71%)
ALGN : 208.58 (+1.73%)
Align Technology (ALGN) Q3 2024 Earnings Call Transcript

ALGN earnings call for the period ending September 30, 2024.

ALGN : 208.58 (+1.73%)
Align Technology: Q3 Earnings Snapshot

Align Technology: Q3 Earnings Snapshot

ALGN : 208.58 (+1.73%)
Will These 3 MedTech Stocks Surpass Q3 Earnings Forecasts?

The third-quarter 2024 earnings season has just kicked off for the MedTech space, with a number of bigwigs scheduled to release their results this week. Per the latest Earnings Preview, quarterly results...

BSX : 83.62 (-0.48%)
TMO : 557.92 (+2.12%)
ALGN : 208.58 (+1.73%)
Stocks Settle Higher as US Banks Post Solid Earnings Results

The S&P 500 Index ($SPX ) (SPY ) Friday closed up by +0.61%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.97%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +0.15%. Stocks on...

BLK : 985.08 (+0.41%)
AOS : 75.40 (+0.40%)
$SPX : 5,728.80 (+0.41%)
JPM : 222.94 (+0.46%)
ALGN : 208.58 (+1.73%)
$IUXX : 20,033.14 (+0.72%)
QQQ : 487.43 (+0.74%)
ZNZ24 : 110-010s (-0.40%)
STLA : 13.70 (+0.59%)
TSLA : 248.98 (-0.35%)
WFC : 64.68 (-0.37%)
GNRC : 168.91 (+2.03%)
S&P 500 Climbs to a Record High as US Bank Earnings Impress

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.59%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.76%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.11%. Stocks today are moderately...

BLK : 985.08 (+0.41%)
AOS : 75.40 (+0.40%)
$SPX : 5,728.80 (+0.41%)
JPM : 222.94 (+0.46%)
ALGN : 208.58 (+1.73%)
$IUXX : 20,033.14 (+0.72%)
QQQ : 487.43 (+0.74%)
ZNZ24 : 110-010s (-0.40%)
STLA : 13.70 (+0.59%)
TSLA : 248.98 (-0.35%)
WFC : 64.68 (-0.37%)
$DOWI : 42,052.19 (+0.69%)
What You Need to Know Ahead of Align Technology's Earnings Release

Align Technology will release its third-quarter earnings this month, and analysts anticipate a double-digit bottom-line growth.

XLV : 147.74 (+0.59%)
$SPX : 5,728.80 (+0.41%)
ALGN : 208.58 (+1.73%)
PIPR : 283.66 (+0.01%)
Is Align Technology Stock Underperforming the S&P 500?

Despite Align Technology’s underperformance compared to the S&P 500 Index over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

$SPX : 5,728.80 (+0.41%)
XRAY : 23.49 (+1.38%)
ALGN : 208.58 (+1.73%)
Is Cooper Companies Stock Outperforming the Nasdaq?

Cooper Companies has recently outperformed in the Nasdaq, and Wall Street analysts are bullish about the stock’s prospects.

COO : 105.85 (+1.12%)
$NASX : 18,239.92 (+0.80%)
CMS : 68.30 (-1.88%)
ALGN : 208.58 (+1.73%)
Are Wall Street Analysts Bullish on Align Technology Stock?

Despite Align Technology’s underperformance relative to the broader market over the past year, Wall Street analysts remain moderately bullish about the stock’s prospects.

ALGN : 208.58 (+1.73%)
$SPX : 5,728.80 (+0.41%)
MDEV : 21.47 (+1.40%)

Barchart Exclusives

Thanks to Wall Street, Novo Nordisk Stock is Now a Buy
Novo Nordisk has lost about a quarter of its value since the end of June. Meanwhile, indications are that its diabetes and weight-loss drugs may be useful in fighting cardiovascular disease, arthritis, opioid and alcohol addiction, and Alzheimer's. Novo remains a leader in the sector, and is trading at a valuation a third cheaper than competitor, Eli Lilly. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar